Attenuated HIV vaccine: Caveats [1]

Science

Volumn 271, Issue 5257, 1996, Pages 1790-1792

  Ruprecht, R M ^a   Baba, T W ^a   Liska, V ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AUTOIMMUNITY; CASE REPORT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ATTENUATION;

AIDS VACCINES; ANIMALS; GENES, NEF; HIV INFECTIONS; HIV-1; HUMANS; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINES, ATTENUATED; VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030007364     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)